A phage-encoded anti-CRISPR protein co-opts host enolase to prevent type III CRISPR immunity

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Nature Microbiology

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41564-025-02178-2PMID 41219509PMCID PMC12811900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Phage Variable Region Encodes Anti-CRISPR Proteins Inhibiting All Streptococcus thermophilus CRISPR Immune Systems

  2025influential reference
• Strengthening phage resistance of Streptococcus thermophilus by leveraging complementary defense systems

  2024cited by this paper
• Cas10 relieves host growth arrest to facilitate spacer retention during type III-A CRISPR-Cas immunity

  2024cited by this paper
• AcrIIIA1 is a protein–RNA anti-CRISPR complex that targets core Cas and accessory nucleases

  2024cited by this paper
• Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies

  2024influential reference
• Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus

  2024influential reference
• The structural biology of type III CRISPR-Cas systems.

  2024cited by this paper
• Structural basis for the activity of the type VII CRISPR–Cas system

  2024cited by this paper
• Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus

  2023cited by this paper
• Molecular basis for inhibition of type III-B CRISPR-Cas by an archaeal viral anti-CRISPR protein.

  2023cited by this paper
• An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover

  2023cited by this paper
• Dairy phages escape CRISPR defence of Streptococcus thermophilus via the anti-CRISPR AcrIIA3.

  2023cited by this paper
• The highly diverse antiphage defence systems of bacteria

  2023cited by this paper
• Bacterial defences: mechanisms, evolution and antimicrobial resistance

  2023cited by this paper
• Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins.

  2023cited by this paper
• Discovery of potent and versatile CRISPR–Cas9 inhibitors engineered for chemically controllable genome editing

  2022cited by this paper
• OUP accepted manuscript

  2022cited by this paper
• Bacteriophage protein PEIP is a potent Bacillus subtilis enolase inhibitor.

  2022influential reference
• Structural and biochemical characterization of in vivo assembled Lactococcus lactis CRISPR-Csm complex

  2022cited by this paper
• Critical roles for ‘housekeeping’ nucleases in type III CRISPR-Cas immunity

  2022cited by this paper
• SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation

  2021cited by this paper
• Unique properties of spacer acquisition by the type III-A CRISPR-Cas system

  2021cited by this paper
• Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

  2021cited by this paper
• Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System

  2021cited by this paper
• Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.

  2020cited by this paper
• Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.

  2019influential reference
• Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry

  2019cited by this paper
• A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity

  2019cited by this paper
• A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system

  2019cited by this paper
• Inhibition of Type III CRISPR-Cas Immunity by an Archaeal Virus-Encoded Anti-CRISPR Protein.

  2019influential reference
• Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

  2019cited by this paper
• A viral ring nuclease anti-CRISPR subverts type III CRISPR immunity

  2019cited by this paper
• Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants

  2019cited by this paper
• Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins

  2018cited by this paper
• The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems

  2018cited by this paper
• Programmable type III-A CRISPR-Cas DNA targeting modules

  2017cited by this paper
• Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

  2017cited by this paper
• A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems

  2017cited by this paper
• RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex

  2016cited by this paper
• The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease

  2016cited by this paper
• Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system

  2016cited by this paper
• Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6

  2016cited by this paper
• Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.

  2015cited by this paper
• A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.

  2015cited by this paper
• An updated evolutionary classification of CRISPR–Cas systems

  2015cited by this paper
• Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.

  2014cited by this paper
• CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages

  2014cited by this paper
• The three major types of CRISPR‐Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus

  2014cited by this paper
• Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex

  2014cited by this paper
• An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference

  2014cited by this paper
• Staphylococcus epidermidis Csm1 is a 3′–5′ exonuclease

  2013cited by this paper
• α-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps*

  2012cited by this paper
• An octamer of enolase from Streptococcus suis

  2012cited by this paper
• Molecular recognition between Escherichia coli enolase and ribonuclease E

  2010cited by this paper
• RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.

  2009cited by this paper
• Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes

  2008cited by this paper
• Enolases from Gram-positive bacterial pathogens and commensal lactobacilli share functional similarity in virulence-associated traits.

  2007cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites.

  2004cited by this paper
• Multifunctional alpha-enolase: its role in diseases.

  2001cited by this paper
• Crystal structure of the Escherichia coli RNA degradosome component enolase.

  2001cited by this paper
• Multifunctional α-enolase: its role in diseases

  2001cited by this paper
• Structural and mechanistic studies of enolase.

  1996cited by this paper

• A Phage Variable Region Encodes Anti-CRISPR Proteins Inhibiting All Streptococcus thermophilus CRISPR Immune Systems

  2025cites this paper